Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 6.75
-0.06 (-0.88%)
Jul 17, 2026, 4:10 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 358.12 million as of July 17, 2026. Its market cap has increased by 102.71% in one year.
Market Cap
358.12M
Enterprise Value
347.77M
Revenue
2.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.75
ChartMarket Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 358.12M, an increase of 135.60%. That is a compound annual growth rate of 126.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 358.12M | 116.93% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 865.55M |
| Clinuvel Pharmaceuticals | 500.24M |
| Racura Oncology | 416.54M |
| Starpharma Holdings | 299.02M |
| Orthocell | 197.38M |
| Actinogen Medical | 153.63M |
| Dimerix | 144.10M |
| Alterity Therapeutics | 128.33M |